Crown Laboratories Now Operates Under the Name Revance
This change marks a significant milestone in the company's strategic transformation following its recent acquisition of Revance Therapeutics, Inc., a biotechnology company known for its cutting edge innovation in aesthetics and therapeutics, which joins Crown's deep roots in science-driven brands for skin health and rejuvenation.
"The transition to the Revance name marks an exciting new chapter for our company, representing the future of our combined portfolio of advanced, science-driven brands that are designed to address the ever-changing needs of patients, clinicians, and consumers worldwide," said
Revance was chosen as the name that best represents the newly combined company mission to revolutionize the aesthetics and skincare industry through science-based, innovative products.
Bedard continued, "By uniting our complementary market-leading products and incredibly talented teams under one powerful brand, we are strengthening our unique position in the marketplace and unlocking exciting new opportunities for growth. Importantly, our dedication to excellence, innovation, and serving our customers remains unchanged. We look forward to continuing to execute on our successful integration and go-forward strategy, as we aim to become a global leader in injectables, skin quality and skincare solutions."
About Revance
Revance is a fast-growing global aesthetics and skincare company focused on providing innovative aesthetics and market-leading skincare offerings throughout every stage of life. With a differentiated portfolio of products spanning 60 countries, Revance meets the evolving needs of patients and consumers worldwide through continued innovation and commercialization of new products and treatments.
Learn more at Revance.com, RevanceAesthetics.com, CrownLaboratories.com, and CrownAesthetics.com.
View original content to download multimedia:https://www.prnewswire.com/news-releases/crown-laboratories-now-operates-under-the-name-revance-302415183.html
SOURCE Crown Laboratories, Inc.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- PRAGMATIC PLAY UNLEASHES THE POWER OF ANCIENT EGYPT IN 'FURY OF ANUBIS'
- DAVION HEALTHCARE ANNOUNCES PROPOSED ACQUISITION OF HUMASKAN AND ESTABLISHMENT OF UK FINANCE SUBSIDIARY TO SUPPORT STRATEGIC ACQUISITION PROGRAMME
- Circulate Health announces exclusive partnership with Reborne to bring its advanced therapeutic plasma exchange protocols to UK for first time
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesRelated Entities
Definitive AgreementSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share